Skip to main content

potassium hydrogen carbonate / potassium citrate (Sibnayal®)

 

Status: Excluded due to NICE appraisal

Product meets AWMSG exclusion criteria due to NICE appraisal TA838: Slow-release potassium bicarbonate and potassium citrate for treating distal renal tubular acidosis (terminated)

Medicine details

Medicine name potassium hydrogen carbonate / potassium citrate (Sibnayal®)
Formulation 8 meq, 24 meq prolonged release granules
Reference number 4276
Indication

Treatment of distal renal tubular acidosis (dRTA) in adults, adolescents and children aged one year and older

Company Advicenne
BNF chapter Endocrine system
Submission type N/A
Status Excluded due to NICE appraisal
Date of issue 21/06/2021
NICE guidance

TA838: Slow-release potassium bicarbonate and potassium citrate for treating distal renal tubular acidosis (terminated)

Follow AWTTC: